Intellectual property rights trump the right to health: Canada’s Access to Medicines Regime and TRIPs flexibilities in the context of Bolivia’s quest for vaccines

The failure of the Canadian pharmaceutical company Biolyse Pharma to obtain authorization under Canada’s Access Medicines Regime (CAMR) produce 15 million badly needed doses a generic copy vaccine by developing country is occasion for reflection on right health and compatibility this with dominant system intellectual property rights (IPR) 1994 Agreement Trade-Related Aspects Intellectual Property Rights (TRIPS), Doha Declaration subsequent decisions. Global justice are difficult reconcile because patent-supported pricing limits equitable access medicines and, in addition, produces distortions allocation resources research. A ‘delinkage’ production development costs therefore called for. In spite this, governments countries an important sector often hesitant agree sharing information technologies. ‘flexibilities’ (mainly ‘waivers’ ‘compulsory licenses’) provided TRIPS not applied serious consistent way order allow deal crises, as illustrated extreme variation rates vaccination between developed less world.